Showing results (851-860 of 3,473) with videos related to

Sort By:
Pageof 348
Clinical Pharmacokinetics|October 7, 2010
Fluoxetine disposition in patients with chronic hepatitis C treated with interferon-αMario Furlanut, Giorgio Soardo, Debora Donnini, et al.
Clinical Pharmacokinetics|September 1, 1977
The effects of urine pH and plasma protein binding on the renal clearance of disopyramideJ L Cunningham, D D Shen, I Shudo, et al.
Clinical Pharmacokinetics|May 21, 2010
Renal insufficiency has no effect on the pharmacokinetics of vicriviroc in a ritonavir-containing regimenClaudia Kasserra, Angela Sansone-Parsons, Anther Keung, et al.
Clinical Pharmacokinetics|September 30, 2010
A pharmacokinetic and pharmacodynamic study of oral oxycodone in a human experimental pain model of hyperalgesiaAnne E Olesen, Richard Upton, David J R Foster, et al.
Clinical Pharmacokinetics|August 10, 2010
Routine plasma anti-Xa monitoring is required for low-molecular-weight heparinsHesham S Al-Sallami, Michael A Barras, Bruce Green, et al.
Clinical Pharmacokinetics|August 10, 2010
Dipeptidylpeptidase-4 inhibitors (gliptins): focus on drug-drug interactionsAndré J Scheen
Clinical Pharmacokinetics|July 9, 2010
Clinical pharmacokinetics of therapeutic monoclonal antibodiesRon J Keizer, Alwin D R Huitema, Jan H M Schellens, et al.
Clinical Pharmacokinetics|July 9, 2010
Population pharmacokinetics of gemcitabine and its metabolite in Japanese cancer patients: impact of genetic polymorphismsEmiko Sugiyama, Nahoko Kaniwa, Su-Ryang Kim, et al.
Clinical Pharmacokinetics|January 19, 2011
Quantitative prediction of human pharmacokinetics for monoclonal antibodies: retrospective analysis of monkey as a single species for first-in-human predictionJennifer Q Dong, David H Salinger, Christopher J Endres, et al.
Clinical Pharmacokinetics|June 10, 2010
Pharmacological issues of linezolid: an updated critical reviewAntonello Di Paolo, Paolo Malacarne, Emanuele Guidotti, et al.
Pageof 348